Related Experiment Video
Updated: Sep 3, 2025

Author Spotlight: Advancements and Challenges in Surgical Treatments for Postamputation Pain
Published on: March 8, 2024
Meralgia paresthetica mimic after Moderna COVID‑19 vaccine
1TUFTS Neurology, Tufts Medical Center, 60 Tremont Street Biewend, Building, 12th Floor, Boston, MA, 02116, USA. PeterTatum1@gmail.com.
Abstract:
This report describes the case of a 56-year-old male who developed unilateral right anterior thigh numbness which began 16 hours after receiving his second Moderna COVID-19 vaccine in the left deltoid. The numbness persisted and after one week a circular, raised, painless area with a red border appeared in the center of the anterior thigh which resolved after 2 weeks spontaneously. There was no clinical history or risk factors consistent with meralgia paresthetica. At his 6 month follow up the patient reported that his symptoms spontaneously resolved. While many other non-specific neurologic side effects of COVID-19 vaccines have been documented, this is the first case of meralgia paresthetica documented after a vaccine without any other risk factors for the syndrome. COVID vaccines should be considered as a potential cause of very localized peripheral neuropathy.
Related Concept Videos
Myocarditis II: Clinical Features and Diagnostic Tests
Local Anesthetics: Adverse Effects
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Myocarditis III: Medical Management
Peripherally and Centrally Acting Muscle Relaxants: A Comparison
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
Pericarditis III: Medical Management
Skeletal Muscle Relaxants: Adverse Effects
Unlike...

